Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
2271 |
|
| Actual shortage: | 53 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 19 (1%) | |
| Resolved: | 2199 (97%) | |
Discontinuation Reports |
124 |
|
| To be discontinued: | 4 (3%) | |
| Discontinued: | 118 (95%) | |
| Reversed: | 2 (2%) | |
Late reports |
452 (19%) |
|
Overdue reports |
11 (19%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SANDOZ IRBESARTAN HCT | 150MG 12.5MG | TABLET | Resolved | 2020-09-21 | 2020-10-27 | 124600 |
| SANDOZ IRBESARTAN HCT | 150MG 12.5MG | TABLET | Resolved | 2020-09-21 | 2020-10-27 | 124606 |
| SANDOZ IRBESARTAN HCT | 300MG 12.5MG | TABLET | Resolved | 2020-09-21 | 2020-10-27 | 124609 |
| SANDOZ IRBESARTAN HCT | 300MG 12.5MG | TABLET | Resolved | 2020-09-21 | 2020-10-27 | 124612 |
| SANDOZ IRBESARTAN HCT | 300MG 25MG | TABLET | Resolved | 2020-09-21 | 2020-10-27 | 124617 |
| SANDOZ IRBESARTAN HCT | 300MG 25MG | TABLET | Resolved | 2020-09-21 | 2020-10-27 | 124621 |
| SANDOZ IRBESARTAN HCT | 150MG 12.5MG | TABLET | Resolved | 2020-11-27 | 2020-12-09 | 129102 |
| SANDOZ IRBESARTAN HCT | 150MG 12.5MG | TABLET | Resolved | 2021-01-12 | 2021-03-08 | 131394 |
| SANDOZ IRBESARTAN HCT | 25MG 300MG | TABLET | Resolved | 2021-10-19 | 2021-10-26 | 147570 |
| SANDOZ IRBESARTAN HCT | 25MG 300MG | TABLET | Resolved | 2023-02-14 | 2023-03-28 | 184632 |
| SANDOZ IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2023-03-06 | 2023-03-28 | 186285 |
| SANDOZ IRBESARTAN HCT | 12.5MG 150MG | TABLET | Resolved | 2023-03-13 | 2023-04-18 | 186967 |
| SANDOZ IRBESARTAN HCT | 12.5MG 150MG | TABLET | Resolved | 2023-03-13 | 2023-05-03 | 186971 |
| SANDOZ IRBESARTAN HCT | 25MG 300MG | TABLET | Resolved | 2023-07-31 | 2024-01-09 | 200534 |
| SANDOZ IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2023-08-07 | 2023-08-15 | 201264 |
| SANDOZ IRBESARTAN HCT | 25MG 300MG | TABLET | Resolved | 2023-09-19 | 2024-01-09 | 204738 |
| SANDOZ IRBESARTAN HCT | 12.5MG 150MG | TABLET | Resolved | 2023-11-06 | 2023-12-12 | 209216 |
| SANDOZ IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2023-12-04 | 2024-01-18 | 212445 |
| SANDOZ IRBESARTAN HCT | 12.5MG 150MG | TABLET | Resolved | 2024-01-03 | 2024-02-19 | 214777 |
| SANDOZ IRBESARTAN HCT | 12.5MG 150MG | TABLET | Resolved | 2024-06-25 | 2024-07-30 | 231202 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TOBRAMYCIN INHALATION SOLUTION | 300MG | SOLUTION | Discontinued | 2021-09-02 | 2021-09-02 | 145015 |
| VITAMIN B12 | 100MCG | LIQUID | Discontinued | 2017-06-06 | 2017-07-01 | 12133 |
| ZOFRAN ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2022-12-08 | 2023-03-14 | 177540 |
| ZOFRAN ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2023-03-14 | 2023-03-14 | 187062 |